Key facts
- This page summarizes Michael P. Dillon's Form 4 filing for IDEAYA Biosciences, Inc. (IDYA).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Oct 2021, 16:11.
Michael P. Dillon - 04 Oct 2021 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)
- Reporting relationship
- SVP, Chief Scientific Officer
- Issuer ticker
- IDYA
- Reported as of
- 04 Oct 2021
- Net transaction value
- -$22,925
- SEC form
- 4
- Accepted by SEC
- 07 Oct 2021, 16:11:25 UTC
- Prior SEC filing
- 09 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason Throne, as Attorney-in-Fact for Michael P. Dillon
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael P. Dillon filed Form 4 for IDEAYA Biosciences, Inc. (IDYA) on 07 Oct 2021.
Change
- Previous filing in this sequence was filed on 09 Sep 2021.
- Current net transaction value: -$22,925.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDYA
transaction
Common Stock
Options Exercise
- Transaction value
- $16,620
- Shares
- +1,500
- Change %
- +1.9%
- Price
- $11.08
- Shares after
- 80,289
- Date
- 04 Oct 2021
- Ownership
- Direct
IDYA
transaction
Common Stock
Sale
- Transaction value
- $12,924
- Shares
- -500
- Change %
- -0.62%
- Price
- $25.85
- Shares after
- 79,789
- Date
- 04 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F2
IDYA
transaction
Common Stock
Sale
- Transaction value
- $26,621
- Shares
- -1,000
- Change %
- -1.3%
- Price
- $26.62
- Shares after
- 78,789
- Date
- 04 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDYA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,500
- Change %
- -6%
- Price
- $0.000000
- Shares after
- 23,437
- Date
- 04 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,500
- Exercise price
- $11.08
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
Footnote F2
This transaction was executed in multiple trades in prices ranging from $25.39 to $26.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F3
This transaction was executed in multiple trades in prices ranging from $26.42 to $26.92, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F4
25% of the shares subject to the option vest on the first anniversary measured from February 19, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.